TB-500
Thymosin Beta-4 Fragment (amino acids 17-23)
Synthetic version of the active region of thymosin beta-4, a naturally occurring protein found in virtually all human cells. Works systemically for tissue repair.
At a glance
- Half-life
- ~2 h ~2 hours plasma. Tissue residence time significantly longer; supports twice-weekly dosing.
- Routes
- SubQ
- Vial sizes
- 5 mg · 10 mg
- Evidence base
- 2 studies 1 review · 1 preclinical
Mechanism
Primary regulator of monomeric actin (G-actin) availability: sequesters 40-50% of the G-actin pool. Controls cytoskeletal reorganization for cell migration. Promotes angiogenesis, stem cell mobilization, inflammatory cytokine downregulation, and ECM remodeling.
Dosing
No standardized human dosing has been established. Every catalogued study for TB-500 is preclinical or a literature review. Amounts used in animal models do not translate directly to humans.
Published evidence
-
Review 2012
Thymosin beta 4: a multi-functional regenerative peptide
Comprehensive review of TB4's regenerative role across wound healing, cardioprotection, and neuroprotection.
-
Animal in vivo 1999
Thymosin beta4 accelerates wound healing
42% increased reepithelialization at day 4, 61% at day 7 vs controls.
Reported side effects
- Injection site irritation
- Common Mild · Redness, swelling, tenderness. Self-resolving within 24 hours.
- Fatigue/lethargy
- Occasional Mild · Temporary
- Headache
- Occasional Mild
- Cancer risk (theoretical)
- Theoretical Serious · Pro-angiogenic properties could theoretically support tumor vascularization. Treated as contraindicated in active malignancy.
Interactions
-
BPC-157 Synergy
The 'Wolverine Stack.' Complementary healing phases: TB-500 suppresses inflammation systemically, BPC-157 drives local repair.
Reconstitution and storage
Typical: 2mL BAC water per 5mg vial. Store refrigerated 2-8C. Use within 21-28 days.
Lyophilized: freezer. Reconstituted: refrigerate, use within 3-4 weeks.